Abdominal Aortic Aneurysm Genetic Associations: Mostly False? A Systematic Review and Meta-analysis by Bradley, D T et al.
Abdominal Aortic Aneurysm Genetic Associations: Mostly
False? A Systematic Review and Meta-analysis
Bradley, D. T., Badger, S. A., McFarland, M., & Hughes, A. E. (2016). Abdominal Aortic Aneurysm Genetic
Associations: Mostly False? A Systematic Review and Meta-analysis. European Journal of Vascular
Endovascular Surgery, 51(1), 64-75. DOI: 10.1016/j.ejvs.2015.09.006
Published in:
European Journal of Vascular Endovascular Surgery
Document Version:
Peer reviewed version
Queen's University Belfast - Research Portal:
Link to publication record in Queen's University Belfast Research Portal
Publisher rights
© 2016 Elsevier Ltd.
This manuscript version is made available under the CC-BY-NC-ND 4.0 license http://creativecommons.org/licenses/by-nc-nd/4.0/ which
permits distribution and reproduction for non-commercial purposes, provided the author and source are cited.
General rights
Copyright for the publications made accessible via the Queen's University Belfast Research Portal is retained by the author(s) and / or other
copyright owners and it is a condition of accessing these publications that users recognise and abide by the legal requirements associated
with these rights.
Take down policy
The Research Portal is Queen's institutional repository that provides access to Queen's research output. Every effort has been made to
ensure that content in the Research Portal does not infringe any person's rights, or applicable UK laws. If you discover content in the
Research Portal that you believe breaches copyright or violates any law, please contact openaccess@qub.ac.uk.
Download date:15. Feb. 2017
1 
 
Title: Abdominal Aortic Aneurysm Genetic Associations: Mostly False? A Systematic 
Review and Meta-Analysis 
 
Declan T Bradleya  dbradley09@qub.ac.uk (corresponding) 
Stephen A Badgerb   stephenbadger@btinternet.com 
Marie McFarlandc  marie.mcfarland@belfasttrust.hscni.net 
Anne E Hughesa1  annehughes169@btinternet.com 
a. Centre for Public Health, School of Medicine, Dentistry and Biomedical 
Sciences, Queen’s University Belfast, Institute of Clinical Sciences, Block B, 
Royal Victoria Hospital, Belfast BT12 6BA, UK 
b. Mater Misericordiae University Hospital, Eccles Street, Dublin, Ireland 
c. Department of Pathology, Institute of Pathology Building, Royal Victoria 
Hospital, Belfast Health and Social Care Trust, Grosvenor Road, Belfast, 
BT12 6BL 
1.  Recently retired, formerly of QUB.  
 
Category: Review 
Short title (50 characters): AAA genetics: Systematic Review and Meta-analysis 
 
Word count including references: 4,995 
  
2 
 
 
Abstract 
Background 
Many associations between abdominal aortic aneurysm (AAA) and genetic 
polymorphisms have been reported. It is unclear which are genuine and which may 
be caused by type-1 errors, biases and flexible study design.  
Objectives 
To identify associations supported by current evidence and to investigate the effect 
of study design on reporting associations. 
Data Sources 
MEDLINE, Embase and Web of Science. 
Review Methods 
Reports were dual-reviewed for relevance and inclusion against pre-defined criteria 
(studies of genetic polymorphisms and AAA risk). Study characteristics and data 
were extracted using an agreed tool and reports assessed for quality. Heterogeneity 
was assessed using I2 and fixed- and random-effects meta-analyses were conducted 
for variants that were reported at least twice, if any had reported an association. 
Strength of evidence was assessed using a standard guideline. 
Results 
Searches identified 467 unique articles, of which 97 were included. Of 97 studies, 63 
reported at least one association. Of 92 studies that conducted multiple tests, only 
27% corrected their analyses. Two hundred and sixty three genes were investigated 
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and associations were reported in polymorphisms in 87 genes. Associations in 
CDKN2BAS, SORT1, LRP1, IL6R, MMP3, AGTR1, ACE and APOA1 were 
supported by meta-analyses.  
Conclusions 
Uncorrected multiple testing and flexible study design (particularly testing many 
inheritance models and subgroups, and failure to check for Hardy-Weinberg 
Equilibrium) contributed to apparently false associations being reported. 
Heterogeneity, possibly due to the case-mix, geographical, temporal and 
environmental variation between different studies, was evident. Polymorphisms in 
nine genes had strong or moderate support on the basis of the literature at this time. 
We make suggestions for improving AAA genetics study design and conduct.  
 
Key words 
Aortic Aneurysm, Abdominal 
Genetics 
Polymorphism, Single Nucleotide 
Review [Publication Type] 
Meta-Analysis [Publication Type] 
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It has been claimed that most published research findings are false and that studies 
of complex genetic diseases are especially prone to reporting false associations.1 
Abdominal aortic aneurysms (AAA) occur in Mendelian disorders,2 but are usually 
multifactorial. Understanding AAA pathogenesis might lead to new treatments or 
preventive measures. No meaningful personalised genetic risk prediction3 has been 
realised for AAA.  
AAA is usually defined as infra-renal aortic diameter ≥30mm.4 Using alternative 
definitions (infrarenal aortic diameter:suprarenal aortic diameter ratio, or comparison 
to predicted diameter) has striking effects on prevalence.5 Participants may be 
recruited from screening programmes or surgical departments, affecting case-mix. 
The prevalence of old age, tobacco use and medication use has changed over time 
and differs between locations, so gene-environment interactions could affect 
results.6-8 
Ioannidis claimed that six factors increased the likelihood of research findings being 
false: small study size; small effect size; multiple testing; flexible study design; 
financial or other interests and the ‘hotness’ of the field.1 The STrengthening the 
REporting of Genetic Association Studies (STREGA) guidance aims to make reports 
consistent and transparent,9 but there is variation in the analytic and statistical 
methods used. This study aimed to identify gene associations supported by evidence 
and to investigate the role of study design in reporting associations. 
Methods 
Search Strategy 
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We searched databases using MeSH terms (Table 1; Supplementary Methods) on 
25 August 2014. The Medline search was simply “Aortic Aneurysm, Abdominal/ge 
[Genetics]”, limited to human studies. The National Institutes of Health association 
database, references and relevant journals were also searched. 
Inclusion Criteria 
 Population: cases with AAA (infrarenal aorta >30mm, infra-renal/supra-renal 
aortic ratio ≥1.5, surgical repair or ruptured AAA); controls were untested 
individuals, tested controls or hospital controls. 
 Exposure: germline genomic polymorphisms. 
 Comparison: disease risk in individuals with/without polymorphisms or odds of 
exposure in individuals with/without AAA in case-control, cross-sectional or 
cohort studies. 
 Outcome: presence/absence of AAA. 
Exclusion Criteria 
Studies with single-disease controls (e.g. ischaemic heart disease), studies of 
somatic mutations, linkage studies and studies of AAA growth or size were excluded. 
Study Selection and Data Abstraction 
Two authors independently assessed titles and abstracts for relevance and full 
reports for inclusion. Two authors independently extracted quality and genotype/risk 
data for polymorphisms reported ≥2 times with an association reported at least once. 
Additional characteristics were abstracted by one author 
Data analysis 
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Median study size was calculated for each year. Odds ratios for heterozygotes and 
homozygotes were calculated. Where genotype counts were not available, 
inheritance models from original reports were used. Additive model analyses were 
conducted using binary logistic regression in IBM SPSS Statistics v19.0 (IBM Corp, 
Armonk, NY), with genotypes coded as 0, 1 or 2. We re-analysed original CRP data 
from Badger et al.10 to allow meta-analysis with the results of Saratzis et al..11 Hardy 
Weinberg Equilibrium (HWE) deviation was assessed by Haldane's Exact test in 
HardyWeinberg in R. Sensitivity analyses excluded studies with HWE deviation 
(p<0.05). SNP Annotation and Proxy Search (Broad Institute, Cambridge, 
Massachussetts) identifed markers with r2 >0.9. Where study data were published 
more than once (i.e. a study was updated or reported study populations overlapped), 
the selection of the report for inclusion was based on the reporting of genotype 
counts/frequencies or risk in preference to allelic or specific inheritance models. If 
the mode of reporting was the same then the larger study was included. 
Heterogeneity index (I2) and Cochrane’s Q were estimated using meta in R. I2 >50% 
was large, and 25-50% moderate.12 Fixed and random effects inverse variance-
weighted meta-analysis was conducted using meta in R. Significance was p<0.05 in 
fixed effects meta-analysis if I2 <25% or random effects meta-analysis if I2 ≥25%. 
Results 
Search results 
Searches yielded 614 records. Ten were identified from other sources. There were 
477 unique records. Ninety seven were included (Figure 1). Excluded studies are 
listed (Supplementary Table 1).  
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Study types and reports of associations 
There were 91 candidate gene studies, four genome-wide association studies 
(GWAS) and two genetic risk score (GRS) studies (Table 2). Fifty six candidate 
studies, both GRS and all GWAS reported associations. 
Study size and frequency 
Median study size for a candidate gene or GRS study was 710 participants (range 
91-83,024). Study size and frequency of reports increased over time (Figure 2). 
There was a median of three reports/year between 1994 and 25 August 2014.  
Study quality 
Quality indicators (Table 2) and detailed characteristics (Supplementary Table 2) are 
shown. Sixty two studies (64%) reported an association. Ninety two studies reported 
multiple tests and 25 (27%) adjusted analyses for this.  
Genes investigated 
Two hundred and sixty three genes were investigated (Supplementary Table 3), with 
87 associated at least once. The median study size for reports that claimed an 
association was 811, and that of those that did not was 710 (Independent Samples 
Mann-Whitney U standardised test statistic=0.10, p=0.92). 
Selection of polymorphisms for meta-analysis 
We identified genes that featured in at least two studies and that had at least one 
association with sufficient data (Supplementary Table 3; Supplementary Table 4). 
Results of meta-analyses 
8 
 
Meta-analyses are summarised (Table 3) and shown in full (Supplementary Table 5). 
Associations between AAA and 9p21 rs10757278, SORT1 rs599839, LRP1 
rs1466535, MMP3 rs3025058, AGTR1 rs5186, ACE rs4646994 and APOA1 
rs964184 were supported. CRP rs3091244 lost significance in sensitivity analysis. 
MMP2 rs243865 was associated but one of two studies deviated from HWE. Six 
were supported by strong evidence, three by moderate evidence and 25 had weak 
evidence (Table 4). 
Discussion 
Most studies reported associations, but only six were supported by strong evidence. 
Two were reported in genome-wide studies (DAB2IP and LRP1),72,78 and four in 
candidate gene studies (9p21/CDKN2BAS, IL6R, LPA and SORT1).50,93,94,108 There 
was moderate evidence for associations with LDLR, MMP3 and AGTR1 
polymorphisms. MMP3 rs3025058 was tentatively suggested to be an AAA risk 
factor in 1999 in a small study by Yoon et al. though it was not statistically significant 
after correction for multiple testing.18 Subsequent studies appear to support its effect 
in homozygosity. Other associations currently supported by moderate or strong 
evidence were all made since 2008. 
Inter-study inconsistency may be due to heterogeneity of effect, systematic error or 
bias. Multiple testing was usually uncorrected and flexible analysis was common: 
Many studies tested numerous inheritance models and subgroups, reporting 
significance when p<0.05. Several studies claimed HWE, but deviated significantly 
(p<0.05).11,99   
We propose that it may be time for the genetic epidemiology research community to 
consider prospective registration of aetiological studies to avoid flexible post hoc 
9 
 
analyses. Simple standard steps, such as planning for adequate power, using 
contemporaneous controls and presenting counts and risk estimates for genotypes 
rather than assuming models of inheritance, checking frequencies in population 
databases, presenting analyses of HWE deviation and correcting for multiple testing 
would greatly improve the quality of reports in this field.  
Our review excluded studies of aneurysm size or growth, and did not attempt to 
integrate results for 27 associated polymorphisms that had been reported only once. 
Supported associations suggest the importance of lipoproteins. LRP1, LDLR, 
SORT1 and the 9p21 locus affect cholesterol metabolism and atherosclerosis. LRP1 
has other important regulatory roles, including regulation of extracellular matrix 
breakdown by the endocytosis of proteinases.109 LPA produces lipoprotein A which 
increases cardiovascular risk.110  IL6R polymorphisms alter cardiovascular risk, 
possibly through inflammation.111-114 MMP3 affects atherosclerosis and tissue 
remodelling.115 Its association in this review is in agreement with a recent meta-
analysis.116 AGTR1 affects blood pressure, which is consistent with the association 
between hypertension and AAA.6,117 DAB2IP is a tumour-suppressor gene involved 
in cell signalling, survival, migration, maturation and apoptosis.72 Understanding their 
roles may help develop prevention strategies based on understanding key biological 
pathways. Improving future study design will avoid wasteful false associations.  
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Tables 
Table 1. Databases and time periods searched 
Database Date Range 
Medline 1946 - August Week 1 2014 
Embase 1980 – 2014 Week 33 
Web of Science All years – 25 August 2014 
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Table 2. Study Quality 
First Author Year 
Cases 
(n) 
Controls 
(n) 
Ethnicity 
reported 
Controlled 
for ethnicity 
by logistic 
regression 
Tested or 
untested 
controls 
Genotyping 
rate 
reported 
HWE 
Reported 
Multiple 
tests 
Corr. for 
Multiple 
Testing 
Study 
Type 
Reported 
Association 
Ramsbottom13 1994 82 79 Yes No Tested No No Yes No Cand No 
Powell14 1996 232 245 Yes No Untested No No Yes No Cand No 
Ramsbottom15 1997 85 34 No No Tested No No Yes No Cand No 
Hamano16 1999 125 153 No No Tested No Yes No NA Cand No 
Wang17 1999 84 51 No No NR No No Yes No Cand Yes 
Yoon18 1999 47 174 No No Untested Yes Yes Yes Yes Cand No 
Kotani19 2000 58 410 No No Untested No Yes Yes No Cand No 
Rossaak20 2000 190 163 Yes No Untested No No Yes Yes Cand Yes 
Pola21 2001 124 112 Yes No Tested No Yes Yes  No Cand No 
Rasmussen22 2001 102 118 Yes No Untested No No Yes No Cand Yes 
Schillinger23 2002 70 61 No No Tested No No Yes  No Cand Yes 
Unno 24 2002 131 106 No No Untested No Yes Yes No Cand Yes 
Bown25 2003 100 100 Yes No Mixed No Yes Yes No Cand Yes 
Jones26 2003 414 203 No No Untested No Yes Yes No Cand Yes 
Sugimoto27 2003 49 237 No No Untested No No Yes No Cand Yes 
Ghilardi28 2004 70 172 No No Tested No Yes Yes No Cand Yes 
Massart29 2004 99 225 Yes No NR No Yes Yes No Cand Yes 
Fatini30 2005 250 250 Yes No Tested No Yes Yes No Cand Yes 
Fatini31 2005 250 250 Yes No Tested No Yes Yes No Cand Yes 
Jones32 2005 428 282 No No Untested No Yes Yes No Cand No 
Ogata33 2005 387 425 Yes Yes Untested No Yes Yes No Cand Yes 
Schulz34 2005 133 910 Yes No Untested No No Yes No Cand No 
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First Author Year 
Cases 
(n) 
Controls 
(n) 
Ethnicity 
reported 
Controlled 
for ethnicity 
by logistic 
regression 
Tested or 
untested 
controls 
Genotyping 
rate 
reported 
HWE 
Reported 
Multiple 
tests 
Corr. for 
Multiple 
Testing 
Study 
Type 
Reported 
Association 
Strauss35 2005 106 97 No No Untested No Yes Yes No Cand Yes 
Ferrara36 2006 88 44 No No NR No No Yes Yes Cand Yes 
Hinterseher37 2006 51 48 Yes No Untested No Yes Yes No Cand No 
Ogata38 2006 387 426 Yes No Untested No No Yes Yes Cand Yes 
Armani39 2007 146 156 No No Untested No No Yes No Cand No 
Badger40 2007 241 1000 No No Untested No Yes Yes Yes Cand No 
Bown41 2007 389 404 Partial No Tested No Yes Yes  No Cand Yes 
Deguara42 2007 405 405 Yes No Untested No No Yes No Cand Yes 
Golledge43 2007 689 3538 No No Tested Yes Yes Yes Yes Cand No 
Hinterseher44 2007 146 133 Yes No Untested No Yes Yes No Cand No 
Peeters45 2007 88 88 No No Tested No No No NA Cand No 
Waliszewski46 2007 112 50 Yes No Untested No No Yes No Cand Yes 
Bown47 2008 899 815 Yes No Tested No Yes Yes No Cand Yes 
Giusti48 2008 423 423 No No Tested No Yes Yes Yes Cand Yes 
Gotting49 2008 129 129 No No Untested No Yes Yes Yes Cand Yes 
Helgadottir50 2008 2836 16732 Partial No Mixed No Yes Yes No Cand Yes 
Hinterseher51 2008 50 41 Partial No Untested No Yes Yes No Cand Yes 
Jones52 2008 1226 1723 Partial No Mixed No Yes Yes No Cand Yes 
Smallwood53 2008 677 656 No No Tested Yes Yes Yes No Cand Yes 
Smallwood54 2008 678 659 No No Tested Yes Yes Yes No Cand No 
Badger55 2009 230 279 No No Tested No No Yes No Cand No 
Badger10 2009 248 400 No No Tested No No No NA Cand No 
Elmore56,57 2009 950 1146 No No Mixed No No Yes No GWAS Yes 
Golledge58 2009 1294 1460 No No Tested Yes Yes Yes Yes Cand No 
Jones59 2009 567 552 Yes NR Tested No No Yes No Cand No 
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First Author Year 
Cases 
(n) 
Controls 
(n) 
Ethnicity 
reported 
Controlled 
for ethnicity 
by logistic 
regression 
Tested or 
untested 
controls 
Genotyping 
rate 
reported 
HWE 
Reported 
Multiple 
tests 
Corr. for 
Multiple 
Testing 
Study 
Type 
Reported 
Association 
Korcz60 2009 133 152 Yes No Tested No Yes Yes No Cand No 
Lucarini61 2009 201 252 No No Tested No Yes Yes No Cand Yes 
Sandford62 2009 285 273 Yes No Tested No No Yes No Cand No 
Smallwood63 2009 678 659 No No Tested Yes Yes Yes Yes Cand Yes 
Thompson64 2009 741 1366 No No Partial No No Yes No Cand Yes 
Atli65 2010 61 62 No No Tested No No Yes No Cand Yes 
Baas66 2010 736 1024 No No Mixed Yes Yes Yes Yes Cand No 
Baas67 2010 736 1024 No No Mixed Yes Yes Yes Yes Cand Yes 
Baas68 2010 736 1024 No No Mixed Yes Yes Yes Yes Cand No 
Badger69 2010 230 278 Yes No Tested No Yes Yes No Cand No 
Biros70 2010 513 2858 No No Tested No No Yes No Cand Yes 
Golledge71 2010 640 1071 No No Tested Yes Yes Yes Yes Cand No 
Gretarsdottir72 2010 4559 37954 Partial No Mixed No No Yes Yes GWAS Yes 
Moran73 2010 689 3538 No No Tested Yes Yes Yes No Cand Yes 
Obukofe74 2010 1155 996 No No Tested No Yes Yes No Cand No 
Thompson75 2010 1890 3785 Yes No Mixed No Yes Yes No Cand No 
Biros76 2011 834 795 No No Tested No Yes Yes No Cand Yes 
Biros77 2011 1904 2616 No No Mixed No Yes Yes Yes Cand No 
Bown78 2011 6228 49182 No Partial Mixed No Yes Yes Yes GWAS Yes 
Bradley79 2011 434 378 Yes No Tested Yes Yes Yes Yes Cand No 
Hinterseher80 2011 874 899 No No NR No Yes Yes No Cand No 
Katrancioglu81 2011 100 138 No No Tested No No Yes No Cand Yes 
Lillvis82 2011 394 419 No No Untested No Yes Yes Yes Cand Yes 
Roberts83 2011 1238 731 Yes No Tested Yes Yes Yes No Cand Yes 
Bisoendial84 2012 613 707 No No Tested No Yes Yes No Cand No 
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First Author Year 
Cases 
(n) 
Controls 
(n) 
Ethnicity 
reported 
Controlled 
for ethnicity 
by logistic 
regression 
Tested or 
untested 
controls 
Genotyping 
rate 
reported 
HWE 
Reported 
Multiple 
tests 
Corr. for 
Multiple 
Testing 
Study 
Type 
Reported 
Association 
Duellman85 2012 178 178 No No Tested No Yes Yes No Cand Yes 
Helgadottir50 2012 4261 33520 Partial No Mixed No Yes Yes Yes Cand Yes 
Korcz86 2012 300 313 No No Tested No Yes Yes No Cand No 
Oszajca87 2012 153 152 No No Untested No Yes Yes No Cand Yes 
Saracini88 2012 423 423 No No Tested No Yes Yes Yes Cand Yes 
Antoniou89 2013 65 89 Yes No Tested No No No NA Cand Yes 
Bradley90 2013 5138 39273 Partial Partial Mixed Yes Yes Yes Yes GWAS Yes 
Galora91 2013 423 423 No No Tested No Yes Yes Yes Cand Yes 
Gregorek92 2013 117 117 No No Tested No Yes Yes No Cand Yes 
Harrison93 2013 4524 15710 Partial No Mixed Yes Yes No NA Cand Yes 
Jones94 2013 7048 75976 Partial No Mixed Yes Yes Yes No Cand Yes 
Tragante95 2013 651 2015 No No Untested Yes Yes Yes Yes GRS Yes 
van 't Hof96 2013 859 2089 Yes Yes Untested Yes Yes Yes No GRS Yes 
Wong97 2013 318 3930 No No Tested No Yes Yes No Cand No 
Bridge98 2014 602 490 Yes No Tested Yes Yes Yes No Cand Yes 
Cao99 2014 463 463 Yes No Tested No Yes Yes No Cand Yes 
Duellman100 2014 141 168 No No Tested Yes Yes Yes No Cand Yes 
Galora101 2014 423 423 No No Untested No Yes Yes Yes Cand Yes 
Li102 2014 316 306 No No Tested No Yes Yes No Cand Yes 
Mikołajczyk-
Stecyna103 
2014 128 180 No No Tested No Yes Yes No Cand Yes 
Oszajca104 2014 153 152 No No Untested No No Yes No Cand Yes 
Saratzis105 2014 797 793 Partial No Tested No Yes Yes No Cand No 
Saratzis11 2014 722 753 Partial No Tested No Yes Yes No Cand Yes 
Strauss106 2014 518 541 No No Untested No Yes Yes No Cand Yes 
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First Author Year 
Cases 
(n) 
Controls 
(n) 
Ethnicity 
reported 
Controlled 
for ethnicity 
by logistic 
regression 
Tested or 
untested 
controls 
Genotyping 
rate 
reported 
HWE 
Reported 
Multiple 
tests 
Corr. for 
Multiple 
Testing 
Study 
Type 
Reported 
Association 
Wei107 2014 155 310 Yes No Tested Yes Yes Yes No Cand Yes 
NR, Not Reported; NA, Not Applicable; Cand, Candidate Gene Study; GRS, Genetic Risk Score; GWAS, Genome-wide Associaiton 
Study 
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Table 3. Summary of meta-analyses 
Gene and Polymorphism OR (95% CI) p value I2 FE/RE 
9p21 (CDKN2BAS) rs10757278  Heterozygous (A/G) 1.28 (1.16-1.40) 2.9x10-7 7.3% FE 
9p21 (CDKN2BAS) rs10757278  Homozygous (G/G) 1.55 (1.38-1.74) 1.2x10-13 20.1% FE 
ACE Insertion/Deletion (rs4646994)  Heterozygous (D/I) 0.90 (0.72-1.12) 0.34 66.5% RE 
ACE Insertion/Deletion (rs4646994)  Homozygous (I/I) 0.67 (0.50-0.90) 8.0x10-3 72.3% RE 
*ACE Insertion/Deletion (rs4646994)  Heterozygous (D/I)  0.85 (0.71-1.02) 0.08 48.7% RE 
*ACE Insertion/Deletion (rs4646994)  Homozygous (I/I) 0.67 (0.49-0.91) 9.5 x10-3 75.1% RE 
AGTR1 rs5186  Heterozygous (A/C) 1.25 (1.00-1.55) 0.047 53.0% RE 
AGTR1 rs5186  Homozygous (C/C) 1.44 (1.13-1.84) 3.5x10-3 0.6% FE 
AGTR1 rs5186  Allelic Model (C Allele) 1.19 (1.05-1.34) 5.0x10-3 45.6% RE 
APOA1 rs964184  Additive (G allele) 1.20 (1.05-1.37) 6.8x10-3 0.0% FE 
APOB rs1367117  Additive (A Allele) 1.09 (0.95-1.24) 0.24 50.1% RE 
CCR5 rs333  Heterozygous (WT/Del32) 1.34 (0.36-4.94) 0.66 89.5% RE 
CCR5 rs333  Homozygous (Del32/ Del32) 1.73 (0.21-14.09) 0.61 41.2% RE 
CRP rs3091244  Heterozygous (Group B) 1.58 (0.91-2.77) 0.11 87.4% RE 
CRP rs3091244  Homozygous (Group A) 2.16 (1.10-4.24) 0.03 84.0% RE 
*CRP rs3091244  Heterozygous (Group B) 1.25 (0.68-2.30) 0.46 82.5% RE 
*CRP rs3091244  Homozygous (Group A) 1.60 (0.79-3.22) 0.19 74.3% RE 
ELN rs2071307  Heterozygous (A/G) 0.73 (0.46-1.14) 0.16 73.5% RE 
ELN rs2071307  Homozygous (A/A) 0.90 (0.48-1.69) 0.74 77.9% RE 
HMOX1 GT(n) Repeat Heterozygous (GT(≥25)/GT(<25)) 1.21 (0.25-5.85) 0.81 91.7% RE 
HMOX1 GT(n) Repeat Homozygous (GT(<25)/ GT(<25)) 1.03 (0.14-7.58) 0.97 76.4% RE 
IL10 rs1800896  Heterozygous (G/A) 1.26 (0.89-1.78) 0.20 31.1% RE 
IL10 rs1800896  Homozygous (A/A) 1.59 (0.97-2.61) 0.06 53.7% RE 
LRP1 rs1466535  Heterozygous (C/T) 0.93 (0.45-1.93) 0.84 57.5% RE 
LRP1 rs1466535  Homozygous (C/C) 0.85 (0.22-3.32) 0.81 87.8% RE 
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LRP1 rs1466535  Additive (C Allele) 1.09 (1.00-1.19) 0.047 69.5% RE 
*LRP1 rs1466535 Additive (C Allele) 1.15 (1.10-1.21) 2.5x10-10 0.0% FE 
MMP2 rs243865 Heterozygous (C/T) 0.87 (0.60-1.24) 0.43 73.7% RE 
MMP2 rs243865 Homozygous (T/T) 0.65 (0.46-0.93) 0.02 0% FE 
MMP2 rs243865 Dominant (C/T & T/T) 0.82 (0.60-0.15) 0.25 70.9% RE 
MMP3 rs3025058  Heterozygous (6A/5A) 0.84 (0.70-1.02) 0.08 0.0% FE 
MMP3 rs3025058  Homozygous (6A/6A) 0.61 (0.49-0.76) 1.6x10-5 0.0% FE 
MMP9 rs3918242  Heterozygous (C/T) 1.05 (0.92-1.18) 0.48 21.4% FE 
MMP9 rs3918242  Homozygous (T/T) 0.81 (0.49-1.33) 0.41 35.4% RE 
*MMP9 rs3918242  Heterozygous (C/T) 1.08 (0.91-1.27) 0.40 30.7% RE 
*MMP9 rs3918242  Homozygous (T/T) 0.93 (0.61-1.42) 0.75 0% FE 
MMP13 rs2252070  Heterozygous (A/G) 1.08 (0.90-1.29) 0.41 0.0% FE 
MMP13 rs2252070  Homozygous (G/G) 1.16 (0.76-1.77) 0.48 50.7% RE 
MTHFR1 rs1801133  Heterozygous (C/T) 1.06 (0.87-1.30) 0.57 68.6% RE 
MTHFR1 rs1801133  Homozygous (T/T) 1.06 (0.81-1.40) 0.66 60.7% RE 
*MTHFR1 rs1801133 Heterozygous (C/T) 1.07 (0.85-1.36) 0.56 72.3% RE 
*MTHFR1 rs1801133 Homozygous (T/T) 0.96 (0.75-1.21) 0.70 37.1% RE 
NOS3 rs1799983  Heterozygous (G/T) 1.14 (0.84-1.55) 0.39 29.9% RE 
NOS3 rs1799983  Homozygous (T/T) 1.16 (0.52-2.58) 0.71 87.9% RE 
PHACTR1 rs12526453  Additive (C allele) 1.02 (0.86-1.22) 0.80 63.7% RE 
SERPINE1 rs1799889 Heterozygous (4G/5G) 0.90 (0.65-1.24) 0.51 0% FE 
SERPINE1 rs1799889 Homozygous (5G/5G) 1.10 (0.72-1.69) 0.66 0% FE 
*SERPINE1 rs1799889 Heterozygous (4G/5G) 0.92 (0.62-1.38) 0.62 0% FE 
*SERPINE1 rs1799889 Homozygous (5G/5G) 1.19 (0.70-2.03) 0.52 0% FE 
SORT1 rs599839  Additive (G Allele) 0.82 (0.77-0.86) 2.6x10-13 0.0% FE 
TGFBR2 rs1036095  Heterozygous (C/G) 1.23 (0.83-1.81) 0.31 83.1% RE 
TGFBR2 rs1036095  Homozygous (G/G) 1.69 (0.76-3.77) 0.20 88.5% RE 
TGFBR2 rs764522  Heterozygous (C/G) 1.35 (0.91-1.99) 0.13 79.9% RE 
TGFBR2 rs764522  Homozygous (G/G) 1.73 (0.78-3.85) 0.18 86.2% RE 
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TRIB1 rs2954029  Additive (A Allele) 1.06 (0.90-1.24) 0.45 59.0% RE 
* Sensitivity Analysis conducted with exclusion of studies because of deviation from HWE or an extreme outlying result 
OR, Odds Ratio; RE, Random Effects Meta-analysis; FE, Fixed Effects Meta-analysis 
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Table 4. Assessment of Evidence of Association 
Gene Polymorphism 
Amount of 
Evidence Replication 
Protection 
from Bias 
Overall 
Assessment 
3p21 rs7635818 A C C Weak 
9p21 rs10757278 A A A Strong 
ACE rs4646994 A A C Weak 
AGTR1 rs5186 A B B Moderate 
APOA1 rs964184 A C C Weak 
APOE rs439401 A C C Weak 
APOB rs1367117 A C C Weak 
CCR5 rs333 B C C Weak 
CRP rs3091244 A C C Weak 
DAB2IP rs7025486 A A A Strong 
ELN rs2071307 B C C Weak 
HLA-A A2 C C C Weak 
HLA-B B61 C C C Weak 
HMOX1 GT(n) C C C Weak 
IL6R rs7529229 A A A Strong 
IL10 rs1800896 B C B Weak 
LDLR rs6511720 A B A Moderate 
LPA rs10455872 A A A Strong 
LRP1 rs1466535 A A A Strong 
MMP2 rs243865 B C B Weak 
MMP3 rs3025058 A A B Moderate 
MMP9 rs3918242 B C C Weak 
MMP13 rs2252070 C C C Weak 
MTHFR1 rs1801133 B C C Weak 
NOS3 rs1799983 B C B Weak 
PLA2G7 rs16874954 B C C Weak 
PHACTR1 rs12526453 A C C Weak 
SERPINE1 rs1799889 A C C Weak 
SORT1 rs599839 A A A Strong 
TGFBR1 rs10819634 
rs1571590 
rs1626340 
A C C Weak 
TGFBR2 rs1036095 
rs764522 
A C B Weak 
TIMP1 rs4898 C C C Weak 
TIMP2 nt573 G/A C C C Weak 
TRIB1 rs2954029 A C C Weak 
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614 records identified 
through database 
searching 
10 additional records 
identified through other 
sources 
 
477 unique records after 
duplicates removed 
 
477 records screened 
 
341 records excluded 
 
126 full text articles 
assessed for eligibility 
 
28 full text articles 
excluded: 
Not a genetic study 6 
Overlapping publication 3 
Not AAA phenotype 3 
Family study 2 
Review with no new data 2 
No statistical comparisons 2 
Single disease control group 2 
Study of somatic mutations 2 
Study of AAA size or growth 2 
Case group not only AAA 1 
No comparison group 1 
Case-case study 1 
No relevant results 1 
 
 
 
98 studies included in 
qualitative synthesis 
 
65 studies included in 
quantitative synthesis 
(meta-analyses) 
 
